Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)

China flag China · Delayed Price · Currency is CNY
7.31
-0.23 (-3.05%)
Apr 30, 2026, 3:04 PM CST
53.89%
Market Cap 4.35B
Revenue (ttm) 818.16M
Net Income (ttm) 109.50M
Shares Out 577.21M
EPS (ttm) 0.19
PE Ratio 39.44
Forward PE n/a
Dividend 0.29 (3.91%)
Ex-Dividend Date Mar 5, 2026
Volume 25,840,203
Average Volume 41,782,988
Open 7.60
Previous Close 7.54
Day's Range 7.27 - 7.60
52-Week Range 4.74 - 8.47
Beta 0.34
RSI 54.97
Earnings Date Apr 8, 2026

About SHE:002107

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, includ... [Read more]

Sector Healthcare
Founded 2003
Employees 1,018
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002107
Full Company Profile

Financial Performance

In 2025, SHE:002107's revenue was 816.95 million, an increase of 6.96% compared to the previous year's 763.79 million. Earnings were 95.72 million, an increase of 162.93%.

Financial Statements

News

There is no news available yet.